MétaCan
Menu
← Back to cohort
Record W4225272679 · doi:10.21203/rs.3.rs-1598645/v1

Thirteen tumor necrosis factor receptor superfamily gene expression in malignancies and their clinical relevance to immunotherapy: a pan-cancer analysis

2022· preprint· en· W4225272679 on OpenAlexaff
Zheng Dong, Hongyu Zhou

Bibliographic record

VenueResearch Square · 2022
Typepreprint
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsUniversity of British Columbia
FundersSouthern Methodist University
KeywordsBiologyCarcinogenesisCancer researchCancerTumor necrosis factor alphaCancer immunotherapyImmune systemNeuroblastoma RAS viral oncogene homologOncogeneMelanomaImmunologyCancer cellImmunotherapyGeneticsKRASCell cycleColorectal cancer

Abstract

fetched live from OpenAlex

Abstract Background: Although the expression of the tumor necrosis factor receptor superfamily (TNFRSF) genes and their anticancer functions in immune cells have been well described, little is known about the regulatory mechanisms and the clinical relevance of TNFRSF family gene expression in cancer cells. Recent studies indicate that the expression of CD40 (also known as TNFRSF5) is upregulated by RAS/RAF/PI3K pathway inhibition in melanoma cells, and it has the potential to be a predictive biomarker for immune checkpoint blockade (ICB) therapy responses in multiple cancer types. Therefore, we hypothesized that 13 TNFRSF genes with structural similarities to CD40 would be associated with the RAS-mediated oncogenic signaling pathways in melanoma cells and could benefit the prediction of immunotherapy responses in a range of cancers. Furthermore, there is a paucity of comparative gene expression analyses across cancer types (pan-cancer analysis) to reveal different types of cancer that share similar and distinct expression patterns of these TNFRSF genes. Methods: We performed a pan-cancer analysis of the 13 TNFRSF genes in 18,299 samples from 23 cancer types to elucidate their expression alterations in tumorigenesis and their associations with signatures of immune cell infiltration and type I anti-tumor response, as well as the expression of oncogenes and ICB-related genes. In addition, single-cell (n = 169) and bulk (n = 37) RNA-seq data in melanoma samples with different NRAS (neuroblastoma RAS viral oncogene homolog) mutational statuses were used separately to examine the regulation of these TNFRSF genes by NRAS. Ultimately, the evaluation of these TNFRSF genes as biomarkers of immunotherapy responses in seven cancer types (n = 1,257) was performed using the Tumor Immune Dysfunction and Exclusion web platform. Results and conclusions: Our findings demonstrate a comprehensive landscape of expression alterations in the 13 TNFRSF genes across a wide range of malignancies, with an emphasis on the association of these genes with type I anti-tumor T-cell responses and oncogene expression. In melanoma, oncogenic NRAS mutations downregulate the expression of multiple TNFRSF genes at bulk and single-cell levels. Moreover, our study suggests that the expression of the 13 TNFRSF genes could be used as potential biomarkers for predicting response to ICB therapy in certain cancer types with a partially complementary role. These findings will help us better understand the role of these TNFRSF genes in cancer development and treatment, and they may lead to the identification of candidate biomarkers for future clinical research and implications.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.094
GPT teacher head0.428
Teacher spread0.334 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueResearch Square→Same topicCancer Immunotherapy and Biomarkers→French-language works237,207→